Skip to main content

Table 3 HRs (95% CIs) for different endpoints of SHR

From: Prognostic effect of stress hyperglycemia ratio on patients with severe aortic stenosis receiving transcatheter aortic valve replacement: a prospective cohort study

 

Per 0.1 increase in SHR

High vs. low SHR*

All-cause mortality

Model 1

1.11 (1.04–1.19)

1.63 (1.12–2.38)

Model 2

1.12 (1.04–1.21)

1.50 (1.01–2.23)

Model 3

1.19 (1.11–1.28)

1.97 (1.33–2.92)

Model 4

1.18 (1.10–1.27)

1.96 (1.32–2.92)

Cardiovascular mortality or readmission for heart failure

Model 1

1.17 (1.07–1.27)

2.24 (1.32–3.79)

Model 2

1.12 (1.02–1.22)

1.79 (1.04–3.08)

Model 3

1.26 (1.14–1.39)

3.14 (1.76–5.59)

Model 4

1.14 (1.05–1.25)

2.51 (1.47–4.29)

MACE

Model 1

1.13 (1.02–1.24)

1.76 (1.03–3.01)

Model 2

1.12 (1.01–1.23)

1.79 (1.03–3.12)

Model 3

1.10 (1.00–1.21)

1.85 (1.07–3.20)

Model 4

1.15 (1.03–1.28)

1.88 (1.08–3.27)

  1. Model 1: unadjusted
  2. Model 2: adjusted for age, sex, COPD, diabetes mellitus, EuroSCORE II, chronic kidney disease, albumin, hs-CRP, HDL-C, moderate-to-severe mitral regurgitation, left atrial diameter and moderate-to-severe perivalvular leakage in all-cause mortality, and adjusted for diabetes mellitus, coronary heart disease, EuroSCORE II, moderate-to-severe mitral regurgitation, left atrial diameter and moderate-to-severe perivalvular leakage in cardiovascular mortality or readmission for heart failure, and adjusted for previous stroke, coronary heart disease, diabetes mellitus, atrial fibrillation, EuroSCORE II and albumin in MACE
  3. Model 3: adjusted for covariates based on stepwise Cox regression model
  4. Model 4: adjusted for covariates based on Cox LASSO regression model
  5. *The dichotomy of SHR (0.944) was determined by the maximally selected rank statistics
  6. SHR stress hyperglycemia ratio, HR hazard ratio, CI confidence interval, MACE major adverse cardiovascular events